三重阴性乳腺癌:组织病理学特征,基因组学和治疗方法
Beatriz E Adrada1, Tanya W Moseley1, Megha M Kapoor1
1From the Departments of Breast Imaging (B.E.A., T.W.M., M.M.K., M.E.S., M.M.P., F.P., E.S.N., E.A., G.M.R., M.S.G.), Breast Surgical Oncology (T.W.M.), Pathology-Anatomical (L.K.), and Abdominal Imaging (G.M.R.), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1350, Houston, TX 77030.
概括
三阴性乳腺癌 (TNBC) 是一种攻击性的癌症亚型. 像MRI这样的高级成像对于TNBC患者的早期检测和治疗反应评估至关重要.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 遗传学 是一个遗传学.
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种独特的亚型,缺乏激素受体和HER2表达.
- 转移性乳腺癌不成比例地影响年轻和非西班牙裔黑人女性,转移潜力和复发风险更高.
- 由于其生长模式和成像特征,乳房扫描可能对TNBC检测不足.
研究的目的:
- 为了审查TNBC的特征.
- 讨论各种成像模式在TNBC检测和管理中的作用.
- 强调成像生物标志物对预测治疗反应和生存的重要性.
主要方法:
- 关于TNBC诊断,治疗和预后的当前文献的综述.
- 乳房影像,超声波 (美国) 和磁共振成像 (MRI) 用于TNBC检测的比较.
- 使用MRI进行新辅助化疗反应评估的讨论.
主要成果:
- 乳房MRI显示TNBC检测的最高灵敏度.
- 美国优于乳房扫描,但由于良性的特征,存在误诊的风险.
- 核磁共振是评估新辅助化疗反应的首选方式.
结论:
- 转基因癌症需要量身定制的诊断和治疗策略.
- 先进的成像,特别是MRI,对于TNBC管理至关重要.
- 图像和瘤生物标志物将是个性化TNBC治疗和改善患者治疗结果的关键.
相关概念视频
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


